Polymorphisms in some proinflammatory genes (TNFα and β, IL-1β, IL-6, ADAM17) in severe chronic venous disease
Language English Country Great Britain, England Media print-electronic
Document type Journal Article
PubMed
36420762
DOI
10.1111/jdv.18770
Knihovny.cz E-resources
- MeSH
- Chronic Disease MeSH
- Gene Frequency MeSH
- Genetic Predisposition to Disease MeSH
- Genotype MeSH
- Interleukin-1beta genetics MeSH
- Interleukin-6 genetics MeSH
- Polymorphism, Single Nucleotide MeSH
- Cardiovascular Diseases * genetics MeSH
- Humans MeSH
- Lymphotoxin-alpha genetics MeSH
- ADAM17 Protein genetics MeSH
- Tumor Necrosis Factor-alpha * genetics MeSH
- Check Tag
- Humans MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- ADAM17 protein, human MeSH Browser
- Interleukin-1beta MeSH
- Interleukin-6 MeSH
- Lymphotoxin-alpha MeSH
- ADAM17 Protein MeSH
- Tumor Necrosis Factor-alpha * MeSH
BACKGROUND: Chronic venous disease (CVD) is a common disorder of lower extremities. OBJECTIVES: The study was scheduled to investigate the relationship between polymorphisms in major proinflammatory genes TNF α (-238 A/G; -308 A/G), TNF β (NcoI), IL-1β (+3953 T/C); IL-6 (-174 G/C; -596 G/C) and ADAM17 (3'TACE) and CVD risk. Genotype-phenotype study was calculated to test possible association between examined genotypes and phenotypes of CVD. METHODS: Finally, 150 CVD patients and 227 control subjects were enrolled to the study. Genotypes in proinflammatory gene polymorphisms were identified from isolated DNA by PCR method and restriction analysis. RESULTS: Significant differences in genotype distribution/allelic frequencies in TNF β gene, IL-1 β gene and in ADAM17 gene polymorphisms were found between CVD women and control ones. In the genotype-phenotype study, identified genotypes were associated with arterial hypertension (ADAM17, IL-6-men), ischaemic heart disease (TNF α and β genes), diabetes mellitus (ADAM17-women, TNF β-men), age of CVD onset (TNF α and IL-6), ulceration (ADAM17), duration of ulceration (ADAM17), ulceration recurrence (ADAM17-women), home care necessity (TNF α), varices surgery (TNF α), erysipelas development (ADAM17-men) and tumour development (TNF α). CONCLUSION: Studying of these polymorphisms associations can help us better identify patients at higher risk of developing severe CVD.
See more in PubMed
Raffetto JD, Khalil RA. Mechanisms of lower extremity vein dysfunction in chronic venous disease and implications in management of varicose veins. Vessel Plus. 2021;5:36.
Raffetto JD, Ligi D, Maniscalco R, Khalil RA, Mannello F. Why venous leg ulcers have difficulty healing: overview on pathophysiology, clinical consequences, and treatment. J Clin Med. 2020;10:29.
Stana J, Maver U, Potočnik U. Genetic biases related to chronic venous ulceration. J Wound Care. 2019;28:59-65.
Bharath V, Kahn SR, Lazo-Langner A. Genetic polymorphisms of vein wall remodeling in chronic venous disease: a narrative and systematic review. Blood. 2014;124:1242-50.
Youn YJ, Lee J. Chronic venous insufficiency and varicose veins of the lower extremities. Korean J Intern Med. 2019;34:269-83.
Signorelli SS, Malaponte MG, Di Pino L, Costa MP, Pennisi G, Mazzarino MC. Venous stasis causes release of interleukin 1beta (IL-1beta), interleukin 6 (IL-6) and tumor necrosis factor alpha (TNFalpha) by monocyte-macrophage. Clin Hemorheol Microcirc. 2000;22:311-6.
Eberhardt RT, Raffetto JD. Chronic venous insufficiency. Circulation. 2014;130:333-46.
Santler B, Goerge T. Chronic venous insufficiency - a review of pathophysiology, diagnosis, and treatment. J Dtsch Dermatol Ges. 2017;15:538-56.
Zhao R, Liang H, Clarke E, Jackson C, Xue M. Inflammation in chronic wounds. Int J Mol Sci. 2016;17:2085.
Raffetto JD. Pathophysiology of chronic venous disease and venous ulcers. Surg Clin North Am. 2018;98:337-47.
Comerota A, Lurie F. Pathogenesis of venous ulcer. Semin Vasc Surg. 2015;28:6-14.
Kitchens BP, Snyder RJ, Cuffy CA. A literature review of pharmacological agents to improve venous leg ulcer healing. Wounds. 2020;32:195-207.
Tan MKH, Luo R, Onida S, Maccatrozzo S, Davies AH. Venous leg ulcer clinical practice guidelines: what is AGREEd? Eur J Vasc Endovasc Surg. 2019;57:121-9.
Nelson EA, Adderley U. Venous leg ulcers. BMJ Clin Evid. 2016;2016:1902-37.
Bonkemeyer Millan S, Gan R, Townsend PE. Venous ulcers: diagnosis and treatment. Am Fam Physician. 2019;100:298-305.
Kawaguchi M, Suzuki T. Gene expression and in situ localization of ADAM17 during skin wound healing. Int J Dermatol. 2014;53:e229-31.
Wallace HJ, Stacey MC. Levels of tumor necrosis factor-alpha (TNF-alpha) and soluble TNF receptors in chronic venous leg ulcers-correlations to healing status. J Invest Dermatol. 1998;110:292-6.
Wallace HJ, Vandongen YK, Stacey MC. Tumor necrosis factor-alpha gene polymorphism associated with increased susceptibility to venous leg ulceration. J Invest Dermatol. 2006;126:921-5.
Yu Y, Cao Y, Bell B, Chen X, Weiss RM, Felder RB, et al. Brain TACE (Tumor Necrosis Factor-α-Converting Enzyme) contributes to sympathetic excitation in heart failure rats. Hypertension. 2019;74:63-72.
Hajeer AH, Hutchinson IV. Influence of TNF alpha gene polymorphisms on TNF alpha production and disease. Hum Immunol. 2001;62:1191-9.
Pruessmeyer J, Ludwig A. The good, the bad and the ugly substrates for ADAM10 and ADAM17 in brain pathology, inflammation and cancer. Semin Cell Dev Biol. 2009;20:164-74.
Slonková V, Slonková V Jr, Vašků A, Vašků V. Genetic predisposition for chronic venous insufficiency in several genes for matrix metalloproteinases (MMP-2, MMP-9, MMP-12) and their inhibitor TIMP-2. J Eur Acad Dermatol Venereol. 2017;31:1746-52.
Spinarová L, Spinar J, Vasků A, Pávková-Goldbergová M, Ludka O, Tomandl J, et al. Genetics of humoral and cytokine activation in heart failure and its importance for risk stratification of patients. Exp Mol Pathol. 2008;84:251-5.
Tan JH, Price P, Gut I, Stacey MC, Warrington NM, Wallace HJ. Characterization of tumor necrosis factor-α block haplotypes associated with susceptibility to chronic venous leg ulcers in Caucasian patients. Hum Immunol. 2010;71:1214-9.
Orr L, Klement KA, McCrossin L, O'Sullivan Drombolis D, Houghton PE, Spaulding S, et al. A systematic review and meta-analysis of exercise intervention for the treatment of calf muscle pump impairment in individuals with chronic venous insufficiency. Ostomy Wound Manage. 2017;63:30-43.
Bolton L. Exercise and chronic wound healing. Wounds. 2019;31:65-7.
Ramelet AA. Venous ulcer healing: considerations for an optimal protocol. Ann Dermatol Venereol. 2021;148:209-10.
Fukaya E, Flores AM, Lindholm D, Gustafsson S, Zanetti D, Ingelsson E, et al. Clinical and genetic determinants of varicose veins. Circulation. 2018;138:2869-80.
Krysa J, Jones GT, van Rij AM. Evidence for a genetic role in varicose veins and chronic venous insufficiency. Phlebology. 2012;27:329-35.
Grant Y, Onida S, Davies A. Genetics in chronic venous disease. Phlebology. 2017;32:3-5.
